The Alzheimer's Association and Alzheimer's & Dementia: The Journal of the Alzheimer's Association have introduced a new open access journal – creating an additional channel for Alzheimer's and dementia researchers to communicate scientific findings and knowledge. The journal, Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring (DADM), serves as a companion to the Association's flagship journal.
Alzheimer's & Dementia: DADM will concentrate on new research that reports the discovery, development, and validation of assays, instruments, technologies, and algorithmic approaches leading to the accurate detection and tracking of individuals at risk of progressive dementing diseases. Articles will cover a range of topics focused on the early and accurate detection of people with memory complaints and/or asymptomatic individuals at elevated risk of various forms of memory disorders. All forms of biomarkers will be considered, ranging from gene expression and proteomic markers, to imaging, cognitive and functional markers of disease progression or treatment response.
Dr. Peter J. Snyder, senior vice president and chief research officer at Lifespan, a health system headquartered in Providence, Rhode Island, will serve as the editor-in- chief of the journal.
The focus of the new journal is consistent with research categories identified by the Alzheimer's Association and the National Institutes of Health (NIH) to better coordinate Alzheimer's disease research funding. 'Diagnosis, Assessment and Disease Monitoring' was one of five classifications established when the organisations created the Common Alzheimer's Disease Research Ontology (CADRO) system.
Published by Elsevier, Alzheimer's & Dementia: DADM's online-only, open access format allows for faster publication. Articles are accessible without a subscription and carry a digital object identifier (DOI) making them easier for researchers to find and cite. The author, institution or research funder covers the publication costs, nonetheless, each manuscript must meet established standards for acceptance and peer-review. The process is designed to move manuscripts from acceptance to online publication in approximately two weeks.
The Alzheimer's Association plans to launch a second open access journal, Alzheimer's & Dementia: Translational Research & Clinical Interventions, later this spring.
